Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy

Minerva Cardioangiologica

Volumn 55, Issue 6, 2007, Pages 711-720

  Lotrionte, M ^a   Palazzoni, G ^a   Natali, R ^a   Comerci, G ^a   Abbate, A ^b   Loperfido, F ^a   Biondi Zoccai, G ^c,d  

^a CATHOLIC UNIVERSITY   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c UNIVERSITY OF TURIN   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

Anthracyclines; Echocardiography; Toxicity

Indexed keywords

ANTHRACYCLINE;

ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE;

ADULT; ANTHRACYCLINES; BREAST NEOPLASMS; CARDIOMYOPATHIES; DATA INTERPRETATION, STATISTICAL; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38649093917     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998;339:900-5.
2. Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 2004;351:145-53.
3. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
4. Lefrak EA, Pitha J. Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973;32:302-14.
5. Steinherz LJ, Steinherz PG, Tan CT, Heller G, Murphy ML. Cardiac toxicity 4 to 20 years after completing anthracy-cline therapy. JAMA 1991;266:1672-7.
6. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Salan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991;324:808-9.
7. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-130.
8. Isaaz K, Thompson A, Ethevenot G, Cloez JL, Brembilla B, Pernot C. Doppler echocardiographic measurements of flow velocity motion of left ventricular posterior wall. Am J Cardiol 1989;64:66-75.
9. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
10. Sohn DW, Chai IH, Lee DJ, Kim HC, Kim HS, Oh BH et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80.
11. Sebag IA, Handschumacher MD, Ichinose F, Morgan JG, Hataishi R, Rodrigues AC et al. Quantitative assessment of regional myocardial function in mice by tissue Doppler imaging: comparison with hemodynamics and sonomicrometry. Circulation 2005;111:2611-6.
12. Neilan TG, Jassal DS, Perez-Sanz TM, Raher MJ, Pradhan AD, Buys ES et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 2006;27:1868-75.
13. Kilickap S, Barista I, Akgul E, Aytemir K, Aksoyek S, Aksoy S et al. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol 2005;16:798-804.
14. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A et al. Plasma B-type natriuretic peptide levels in systolic heart failure. J Am Coll Cardiol 2004;43:416-22.
15. Sparano JA, Brown DL, Wolff AC. Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers. Drug Saf 2002;25:301-11.
16. Horacek JM, Pudil R, Tichy M, Jebavy L, Strasova A, Praus R et al. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukaemia. Neoplasma 2005;52:430-4.
17. Kapusta L, Thijssen JM, Groot-Loonen J, van Druten JA, Daniels O. Discriminative ability of conventional echocardiography and tissue Doppler imaging techniques for the detection of subclinical cardiotoxic effects of treatment with anthracyclines. Ultrasound Med Biol 2001;27:1605-14.
18. Garcia MJ, Rodriguez L, Ares M, Griffin BP, Klein AL, Stewart WJ et al. Myocardial wall velocity assessment by pulsed Doppler tissue imaging: characteristic findings in normal subjects. Am Heart J 1996;132:648-56.
19. Jarnert C, Mejhert M, Ring M, Persson H, Edner M. Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrioventricular plane displacement technique. Eur J Heart Fail 2000;2:151-61.
20. Galderisi M, Severino S, Cicala S, Caso P. The usefulness of pulsed tissue Doppler for the clinical assessment of right ventricular function. Ital Heart J 2002;3:241-7.
21. Cardinale D, Colombo A, Sandri MT, Lamantia G, Colombo N, Civelli M et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 2006;114:2474-81.
22. Lipshultz SE, Rifai N, Dalton VM, Levy DE, Silverman LB, Lipsitz SR et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukaemia. N Engl J Med 2004;351:145-53.
23. Redfield MM, Gersh BJ, Bailey KR, Rodeheffer RJ. Natural history of incidentally discovered, asymptomatic idiopathic dilated cardiomyopathy. Am J cardiol 1994;74:737-9.
24. Moreb JS, Oblon DJ. Outcome of clinical congestive heart failure induced by anthracycline chemotherapy. Cancer 1992;70:2637-41.
25. Wong M, Johnson G, Shabetai R, Hughes V, Bhat G, Lopez B et al. Echocardiographic variables as prognostic indicators and therapeutic monitors in chronic congestive heart failure. Veterans Affairs cooperative studies V-HeFT I and II. V-HeFT VA Cooperative Studies Group. Circulation 1993;87:V165-V170.
26. St John Sutton M, Pfeffer MA, Plappert T, Rouleau JL, Moye LA, Dagenais GR et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 1994;89:68-75.
27. Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J et al; BEST Trial Echocardiographic Substudy Investigators. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 2005;45:1064-71.
28. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS. Natural history of aymptomatic left ventricular dysfunction in the community. Circulation 2003;108:977-82.
29. Garot J, Derumeaux GA, Monin JL, Duval-Moulin AM, Simon M, Pascal D et al. Quantitative systolic and diastolic transmyocardial velocity gradient assessed by M-mode colour Doppler tissue imaging as reliable indicators of regional left ventricular function after acute myocardial infarction. Eur Heart J 1999;20:593-603.
30. Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W et al. Improvement of cardiac function during enzyme replacement theraphy in patients with Fabry disease: a prospective strain rate imaging study. Circulation 2003;108:1299-301.
31. Weidemann F, Breunig F, Beer M, Sandstede J, Stork S, Voelker W et al. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J 2005;26:1221-7.
32. Aranda JM Jr, Weston MW, Puleo JA, Fontanet HL. Effect of loading conditions on myocardial relaxation velocities determined by Doppler tissue imaging in heart transplant recipients. J Heart Lung Transplant 1998;17:693-7.
33. Derumeaux G, Ovize M, Loufoua J, Andre-Fouet X, Minaire Y, Cribier A et al. Doppler tissue imaging quantitates regional wall motion during myocardial ischemia and reperfusion. Circulation 1998;97:1970-7.
34. Derumeaux G, Mulder P, Richard V, Chagraoui A, Nafeh C, Bauer F et al. Tissue Doppler imaging differentiates physiological from pathological pressure-overload left ventricular hypertrophy in rats. Circulation 2002;105:1602-8.
35. Chetboul V, Escriou C, Tessier D, Richard V, Pouchelon JL, Thibault H et al. Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne's cardiomyopathy. Eur Heart J 2004;25:1934-9.
36. Matoba S, Hwang PM, Nguyen T, Shizukuda Y. Evaluation of pulsed Doppler tissue velocity imaging for assessing systolic function of murine global heart failure. J Am Soc Echocardiogr 2005;18:148-54.
37. Neilan TG, Jassal DS, Perez-Sanz TM, Raher MJ, Pradhan AD, Buys ES et al. Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 2006;27:1868-75.
38. Tassan-Mangina S, Codorean D, Metivier M, Costa B, Himberlin C, Jouannaud C et al. Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study. Eur J Echocardiogr 2006;7:141-6.
39. Kapusta L, Thijssen JM, Groot-Loonen J, Antonius T, Mulder J, Daniels O. Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. Ultrasound Med Biol 2000;26:1099-108.
40. Kapusta L, Groot-Loonen J, Thijssen JM, DeGraaf R, Daniels O. Regional cardiac wall motion abnormalities during and shortly after anthracyclines theraphy. Med Pediatr Oncol 2003;41:426-35.
41. Spallarossa P, Garibaldi S, Altieri P, Fabbi P, Manca V, Nasti S et al. Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro. J Mol Cell Cardiol 2004;37:837-46.
42. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364:141-8.
43. Biondi-Zoccai GG, Agostoni P, Abbate A. Parallel hierarchy of scientific studies in cardiovascular medicine. Ital Heart J 2003;4:819-20.